“…Pancreatic ductal adenocarcinoma (PDAC) is associated with upregulation of SHH, but in mice, SMO is dispensable for PDAC growth, suggesting that misactivation of the HH pathway is not a critical driver of this cancer either (141,142). Moreover, unlike BCC and medulloblastoma, PDAC is associated with loss of cilia (143,144), providing ancillary evidence that the normal HH pathway is not hyperactivated in PDAC. However, PDAC stromal cells, such as fibroblasts and endojci.org Volume 129 Number 2 February 2019 thelial cells, respond to SHH produced by tumor cells, suggesting that paracrine signaling may modulate PDAC progression (145)(146)(147).…”